Effect of preoperative topical nepafenac 0.1% on inflammatory response after uncomplicated cataract surgery in healthy subjects

To determine the effect of preoperative topical Nepafenac administration on anterior chamber flare after uneventful cataract surgery in healthy subjects.

[1]  R. Tuuminen,et al.  Preoperative anti‐inflammatory treatment of diabetic patients does not improve recovery from cataract surgery when postoperatively treated with a combination of prednisolone acetate and nepafenac , 2019, Acta ophthalmologica.

[2]  D. Patel,et al.  Auckland cataract study 2: clinical outcomes of phacoemulsification cataract surgery in a public teaching hospital , 2017, Clinical & experimental ophthalmology.

[3]  S. Mccafferty,et al.  Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo , 2017, BMC Ophthalmology.

[4]  M. Kahook,et al.  Cataract surgery and nonsteroidal antiinflammatory drugs , 2016, Journal of cataract and refractive surgery.

[5]  Colin J. Chu,et al.  Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes. , 2016, Ophthalmology.

[6]  Justis P. Ehlers,et al.  Topical Nonsteroidal Anti-inflammatory Drugs and Cataract Surgery: A Report by the American Academy of Ophthalmology. , 2015, Ophthalmology.

[7]  K. Jørgensen,et al.  Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. , 2014, Ophthalmology.

[8]  R. Zawadzki,et al.  Improving visual outcomes by preserving outer retina morphology in eyes with resolved pseudophakic cystoid macular edema , 2014, Journal of cataract and refractive surgery.

[9]  T. Ristau,et al.  Aqueous flare is increased in patients with clinically significant cystoid macular oedema after cataract surgery , 2013, British Journal of Ophthalmology.

[10]  M. Packer,et al.  Incidence of acute postoperative cystoid macular edema in clinical practice , 2012, Journal of cataract and refractive surgery.

[11]  Rishi P. Singh,et al.  Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy , 2012, Clinical ophthalmology.

[12]  J. Numaga,et al.  Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery , 2011, Journal of cataract and refractive surgery.

[13]  U. Schmidt-Erfurth,et al.  Evaluation of anterior‐segment inflammation and retinal thickness change following cataract surgery , 2011, Acta ophthalmologica.

[14]  B. Henderson,et al.  Clinical pseudophakic cystoid macular edema: Risk factors for development and duration after treatment , 2007, Journal of cataract and refractive surgery.

[15]  F. Öztürk,et al.  Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema , 2007, Journal of cataract and refractive surgery.

[16]  M. Taşkapılı,et al.  Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity. , 2006, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[17]  E. Donnenfeld,et al.  Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: Pharmacokinetic‐response curve , 2006, Journal of cataract and refractive surgery.

[18]  C. McGhee,et al.  The Auckland Cataract Study: co-morbidity, surgical techniques, and clinical outcomes in a public hospital service , 2002, The British journal of ophthalmology.

[19]  R. Nussenblatt,et al.  Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. , 1999, Journal of cataract and refractive surgery.

[20]  C. Roberts,et al.  Pretreatment with topical diclofenac sodium to decrease postoperative inflammation. , 1996, Ophthalmology.